What is the recommended treatment for a patient on dialysis with a urine culture positive for Aerococcus urinae?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Aerococcus urinae in a Dialysis Patient

For a dialysis patient with Aerococcus urinae in urine culture, treat with ampicillin or penicillin, with dosing adjusted for dialysis and administered after each dialysis session. 1, 2

Antibiotic Selection

First-line options:

  • Ampicillin/Penicillin: Aerococcus urinae shows 100% susceptibility to these agents, making them preferred first-line treatments 3
  • Nitrofurantoin: Effective against A. urinae with clinical and microbiological success rates of 71-76%, but should be avoided in patients with renal failure due to nephrotoxicity 4, 5
  • Vancomycin: Alternative for patients with penicillin allergy, with 100% susceptibility reported for Aerococcus species 3

Dosing for dialysis patients:

  • Ampicillin: 1-2g after each dialysis session 5
  • Penicillin G: Dose after dialysis sessions 5
  • Vancomycin: 20 mg/kg loading dose during the last hour of dialysis, then 500 mg during the last 30 minutes of each subsequent dialysis session 5

Treatment Duration and Approach

  • For uncomplicated UTI: 10-14 days of systemic antibiotics 5
  • For complicated infections or bacteremia: 4-6 weeks of therapy 5
  • Consider antibiotic lock therapy as adjunctive treatment if patient has a dialysis catheter 5

Special Considerations for Dialysis Patients

  • Avoid nephrotoxic antibiotics such as aminoglycosides which carry substantial risk of irreversible ototoxicity 5
  • Cephalosporins are generally preferred over aminoglycosides for gram-negative coverage in dialysis patients, but penicillins are more appropriate for Aerococcus 5
  • Antibiotic selection should be based on pharmacokinetic characteristics that permit dosing after each dialysis session 5

Monitoring and Follow-up

  • Obtain surveillance blood cultures 1 week after completion of antibiotic course if a catheter has been retained 5
  • If blood cultures remain positive, remove the catheter and place a new long-term dialysis catheter after obtaining negative blood cultures 5
  • Monitor for clinical response within 2-3 days of initiating therapy 5

Potential Complications

  • A. urinae can cause serious infections including bacteremia, endocarditis, and spondylodiscitis in addition to UTI 1, 6
  • Patients with urinary catheters or chronic urinary retention are at higher risk for complicated infections 1
  • Prompt and culture-specific treatment is critical to avoid clinical progression of the infection 1

Antibiotic Resistance Considerations

  • While generally susceptible to penicillins, resistance to ciprofloxacin has been documented in approximately 10.9% of Aerococcus isolates 3
  • Due to increasing antibiotic resistance, antibiotic susceptibility testing should guide final treatment selection 1

Remember that Aerococcus urinae is increasingly recognized as a pathogen in elderly patients with multimorbidity and those with urologic conditions 1, 6.

References

Research

Three cases of serious infection caused by Aerococcus urinae.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral Therapy for Aerococcus urinae Bacteremia and Thoracic Spondylodiscitis of Presumed Urinary Origin.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.